Your browser doesn't support javascript.
loading
CD4+CD19+ conjugates favor HIV-1 infection and latency during chronic HIV-1 infection.
Zhang, He-Qian; Xia, Peng; Huang, Hui-Huang; Zhang, Chao; Song, Jin-Wen; Jin, Lei; Jiao, Yan-Mei; Shi, Ming; Zhang, Ji-Yuan; Wang, Fu-Sheng.
Afiliação
  • Zhang HQ; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital.
  • Xia P; National Clinical Research Center for Infectious Diseases.
  • Huang HH; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital.
  • Zhang C; National Clinical Research Center for Infectious Diseases.
  • Song JW; Savaid Medical School, University of Chinese Academy of Sciences, Beijing.
  • Jin L; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital.
  • Jiao YM; National Clinical Research Center for Infectious Diseases.
  • Shi M; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital.
  • Zhang JY; National Clinical Research Center for Infectious Diseases.
  • Wang FS; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital.
AIDS ; 34(2): 189-195, 2020 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-31634199
ABSTRACT

OBJECTIVE:

CD4CD19 conjugates play an important role in regulating antibody responses and follicular helper T cells development in animal models. However, little is known regarding the characteristic of CD4CD19 conjugates in humans with chronic HIV-1 infection.

METHODS:

The numbers of CD4CD19 conjugates were counted in 86 HIV-1-infected patients, including 66 typical progressors and 20 complete responders. CD4CD19 conjugates were sorted by flow cytometry and dissociated into CD4 T singlets and CD19 B singlets. The phenotypes of these cells were analyzed in both typical progressors and complete responders, and the levels of HIV-1 DNA in CD4CD19 conjugates were measured in 10 complete responders.

RESULTS:

We identified CD4CD19 cells as one type of T-B conjugate in peripheral blood, and the numbers and percentages of CD4CD19 conjugates decreased with HIV-1 disease progression. Phenotypic analysis showed CD4CD19 conjugates expressed higher levels of surface CD32. mRNA analysis found that the mRNA levels for CD32b were significantly higher compared with CD32a in CD4CD19 conjugates. Further analysis found that CD4CD19 conjugates expressed higher levels of CCR7 and CXCR5 than CD4 T and CD19 B singlets. A virus infectivity assay showed that CD4CD19 conjugates expressed higher levels of HIV-1-p24 than CD4CD19 cells. CD4CD19 conjugates in lymph node from typical progressors expressed higher levels of HIV-1-p24 than CD4CD19 conjugates in respective peripheral blood. Importantly, CD4CD19 conjugates from complete responders contained higher levels of HIV-1 DNA than total CD4 T cells.

CONCLUSION:

Our study indicates that CD4CD19 conjugates actively participate in HIV-1 infection and latency, and may serve as a new cellular target to eliminate latency.
Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Idioma: Inglês Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2020 Tipo de documento: Artigo País de afiliação: China

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Idioma: Inglês Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2020 Tipo de documento: Artigo País de afiliação: China